1HFS
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764,004
Summary for 1HFS
Entry DOI | 10.2210/pdb1hfs/pdb |
Descriptor | STROMELYSIN-1, ZINC ION, CALCIUM ION, ... (5 entities in total) |
Functional Keywords | hydrolase, metalloprotease, matrix metalloprotease-3, proteoglycanase |
Biological source | Homo sapiens (human) |
Cellular location | Secreted, extracellular space, extracellular matrix : P08254 |
Total number of polymer chains | 1 |
Total formula weight | 18902.83 |
Authors | Becker, J.W. (deposition date: 1997-02-13, release date: 1998-02-18, Last modification date: 2024-02-07) |
Primary citation | Esser, C.K.,Bugianesi, R.L.,Caldwell, C.G.,Chapman, K.T.,Durette, P.L.,Girotra, N.N.,Kopka, I.E.,Lanza, T.J.,Levorse, D.A.,MacCoss, M.,Owens, K.A.,Ponpipom, M.M.,Simeone, J.P.,Harrison, R.K.,Niedzwiecki, L.,Becker, J.W.,Marcy, A.I.,Axel, M.G.,Christen, A.J.,McDonnell, J.,Moore, V.L.,Olszewski, J.M.,Saphos, C.,Visco, D.M.,Shen, F.,Colletti, A.,Krieter, P.A.,Hagmann, W.K. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides. J.Med.Chem., 40:1026-1040, 1997 Cited by PubMed Abstract: Carboxyalkyl peptides containing a biphenylylethyl group at the P1' position were found to be potent inhibitors of stromelysin-1 (MMP-3) and gelatinase A (MMP-2), in the range of 10-50 nM, but poor inhibitors of collagenase (MMP-1). Combination of a biphenylylethyl moiety at P1', a tert-butyl group at P2', and a methyl group at P3' produced orally bioavailable inhibitors as measured by an in vivo model of MMP-3 degradation of radiolabeled transferrin in the mouse pleural cavity. The X-ray structure of a complex of a P1-biphenyl inhibitor and the catalytic domain of MMP-3 is described. Inhibitors that contained halogenated biphenylylethyl residues at P1' proved to be superior in terms of enzyme potency and oral activity with 2(R)-[2-(4'-fluoro-4-biphenylyl)ethyl]-4(S)-n-butyl-1,5-pentane dioic acid 1-(alpha(S)-tert-butylglycine methylamide) amide (L-758,354, 26) having a Ki of 10 nM against MMP-3 and an ED50 of 11 mg/kg po in the mouse pleural cavity assay. This compound was evaluated in acute (MMP-3 and IL-1 beta injection in the rabbit) and chronic (rat adjuvant-induced arthritis and mouse collagen-induced arthritis) models of cartilage destruction but showed activity only in the MMP-3 injection model (ED50 = 6 mg/kg iv). PubMed: 9083493DOI: 10.1021/jm960465t PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.7 Å) |
Structure validation
Download full validation report
